Abstract:Background and purpose:Pancreatic carcinoma is a kind of malignant disease with the rising tendency of incidence and poor prognosis.Little progress has been made on the treatment of advanced pancreatic carcinoma during the past 2 decades.The combined mordality for the unresectable pancreatic carcinoma is controversial.We retrospectively reviewed the clinical data and the results of transarterial intervention alone or transarterial intervention combined with radiotherapy,analyzed the prognostic factors for patients with unresectable pancreatic carcinoma.Methods:We retrospective analyzed 105 patients with locally advanced and metastatic pancreatic carcinoma.Univariate and multivariate statistical methods were used to determine significant prognostic factors and therapy program for overall survival(OS).Results:For all patients,the median survival time(MST) was 9.0 months,1-year and 2-year OS were 31.2% and 12.2% respectively.For the locally advanced vs phase Ⅳ patients,the MST,1-year,2-year OS were 9.1 vs 7.6 months,33.2% vs 29.3% and 14.7% vs 9.1% respectively.On univariate analysis,the number of interventional therapy,whether combined with radiotherapy or not,the choice of gemcitabine programs and primary tumor site were important factors for OS.For all 105 patients,the MST of patients who received multiple transarterial therapy was 4.9 months longer than those who had single therapy(12.5 vs 7.6 monthes,P=0.010).1-year and 2-year OS were 51.5% vs 22.2% and 20.7% vs 8.1%.The MST of patients who received combined therapy was 4.3 months longer compared with who had only interventional therapy(11.9 vs 7.6 monthes,P=0.003),1-year,2-year OS were 48.5% vs 21.8% and 27.7% vs 2.7%.The MST of patients who received gemcitabine programs was 2.2 months longer compared with who had other programs(9.8 vs 7.6 monthes,P=0.018),1-year,2-year OS were 37.5% vs 18.8% and 20.3% vs 3.1%.The MST of patients with pancreatic head cancer was 3.0 months longer compared with the patients whose cancer located in pancreatic body or tail(10.5 vs 7.5 monthes,P=0.031),1-year,2-year OS were 40.2% vs 22.0% and 6.3% vs 8.8%.On multivariate analysis,Interventional therapy combined radiotherapy was independent prognostic factor for OS,it could decrease death risk for all patients 46%(95%CI: 0.272-0.891,P=0.047).Conclusion:In the current study,transarterial intervention combined with radiotherapy can improve overall survival among patients with unresectable pancreatic cancer.

Explore of Palliative Treatment for Pancreatic Carcinoma

Comparisons of curative effects from interventional therapy, palliative operation, and palliative operation combined with 125Ⅰ seed implantation for advanced pancreatic carcinoma

Analysis of the Efficacy of Transcatheter Arterial Infusion Chemotherapy in the Treatment of Pancreatic Carcinoma

Multidisciplinary Treatment with Chemotherapy, Targeted Drug, and High-Intensity Focused Ultrasound in Advanced Pancreatic Carcinoma

Result Analysis of Clinical Treatment of Advanced Pancreatic Carcinoma in Patients Undergoing Regional Chemotherapy

A retrospective analysis on survival factors of transarterial chemoembolization for patients of pancreatic carcinoma with liver metastasis

[The Study of Clinical Value of Transarterial Chemical Perfusion As Second-Line Therapy for Late Stage Pancreatic Cancer].

A retrospective analysis of patients with unresectable pancreatic cancer treated with combined transarterial intervention and three dimensional conformal radiotherapy

Strategies and methods for selecting suitable combined interventional therapy for pancreatic carcinoma

Efficacy of continuous arterial perfusion chemotherapy combined with transarterial chemoembolization regional arterial thermal perfusion in the treatment of pancreatic cancer with liver metastases

Treatment of Advanced Pancreatic Cancer by Transarterial Infusion of Gemcitabine

Results of Treatment of Patients with Advanced Pancreatic Carcinoma Treated by Intra-arterial Chemotherapy Combined with 3-D Conformal Radiotherapy

Clinical observation of high intensity focused ultrasound plus S-1 for advanced pancreatic carcinoma

[Value of Combined Therapy in Pancreatic Cancer with a Poor Prognosis: Analysis of 233 Clinical Cases].

IORT and Regional Chemotherapy in Patients with Locally Advanced Pancreatic Carcinoma

The Current Research of Intra-Arterial Chemotherapy on Pancreatic Cancer

Study on Chinese Medicine Combined with Chemotherapy for Treatment of 32 Cases of Advanced Pancreatic Cancer

Palliative Treatment of Colorectal Cancer Combined with Hepatic Metastases in 105 Cases: a Retrospective Analysis

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy

Transcatheter arterial infusion combined with radioactive particles in the treatment of advanced body/tail pancreatic cancer: a retrospective cohort study

Transcatheter Arterial Infusion Combined with Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer